PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+29.36%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.44B
AUM Growth
+$3.44B
Cap. Flow
+$258M
Cap. Flow %
7.49%
Top 10 Hldgs %
43.94%
Holding
127
New
15
Increased
25
Reduced
25
Closed
9

Top Buys

1
RLMD icon
Relmada Therapeutics
RLMD
$83.7M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
$54.4M
3
BLU
BELLUS Health Inc.
BLU
$49.8M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$40.3M
5
CINC
CinCor Pharma, Inc. Common Stock
CINC
$32.4M

Top Sells

1
GBT
Global Blood Therapeutics, Inc.
GBT
$47.2M
2
LLY icon
Eli Lilly
LLY
$32.4M
3
NBIX icon
Neurocrine Biosciences
NBIX
$31.6M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
$25.2M
5
PRCT icon
Procept Biorobotics
PRCT
$20.1M

Sector Composition

1 Healthcare 97.83%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RVMD icon
76
Revolution Medicines
RVMD
$7.43B
$6.12M 0.18%
+310,500
New +$6.12M
ACRS icon
77
Aclaris Therapeutics
ACRS
$223M
$5.37M 0.16%
341,239
– –
NTRA icon
78
Natera
NTRA
$23B
$5.26M 0.15%
+120,000
New +$5.26M
NARI
79
DELISTED
Inari Medical, Inc. Common Stock
NARI
$5.09M 0.15%
+70,000
New +$5.09M
NVNO icon
80
enVVeno Medical
NVNO
$15M
$4.91M 0.14%
781,615
– –
WGS icon
81
GeneDx Holdings
WGS
$3.65B
$4.39M 0.13%
5,000,000
– –
SLGC
82
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.35M 0.13%
1,500,000
– –
TYRA icon
83
Tyra Biosciences
TYRA
$657M
$4.35M 0.13%
494,403
– –
CTIC
84
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$4.28M 0.12%
+735,165
New +$4.28M
ATNX
85
DELISTED
Athenex, Inc. Common Stock
ATNX
$4.18M 0.12%
15,532,467
+2,000,000
+15% +$538K
ABOS icon
86
Acumen Pharmaceuticals
ABOS
$84.2M
$4.01M 0.12%
400,000
-108,532
-21% -$1.09M
PNT
87
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$3.87M 0.11%
500,000
-573,995
-53% -$4.44M
HCAT icon
88
Health Catalyst
HCAT
$228M
$3.78M 0.11%
389,962
-75,200
-16% -$730K
NBTX
89
Nanobiotix
NBTX
$415M
$3.75M 0.11%
1,059,800
– –
YMAB icon
90
Y-mAbs Therapeutics
YMAB
$390M
$3.06M 0.09%
212,018
– –
PYXS icon
91
Pyxis Oncology
PYXS
$91.2M
$3.01M 0.09%
1,528,812
– –
ABSI icon
92
Absci
ABSI
$356M
$2.8M 0.08%
894,346
– –
PSTX
93
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.65M 0.08%
+750,000
New +$2.65M
CLOV icon
94
Clover Health Investments
CLOV
$1.36B
$2.55M 0.07%
1,500,000
– –
RETA
95
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.51M 0.07%
+100,000
New +$2.51M
QTNT
96
DELISTED
Quotient Limited Ordinary Shares
QTNT
$2.43M 0.07%
16,200,818
– –
SNCE
97
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.42M 0.07%
1,500,000
– –
FULC icon
98
Fulcrum Therapeutics
FULC
$353M
$2.38M 0.07%
294,118
– –
TVTX icon
99
Travere Therapeutics
TVTX
$1.75B
$2.24M 0.06%
90,748
-479,336
-84% -$11.8M
PEAR
100
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$1.84M 0.05%
900,548
– –
1 2 3
4
5